def14a
Sonoma Pharmaceuticals - Crunchbase Company Profile & Funding
Oculus Innovative Sciences, Inc. Announces Exercise of Underwriters' Over-Allotment Option
OCULUS INNOVATIVE SCIENCES INC (SNOA) Property, Plant & Equipment (PP&E) By Year And By Quarter
Genetix Biotech partners with Oculus Innovative Sciences; launches 'Mircodacyn Wound Care' - Express Computer
Petaluma's Oculus Innovative Sciences reports quarterly results
Oculus Innovative Sciences | On Sale | EntirelyPets
OCULUS INNOVATIVE SCIENCES INC (SNOA) Property, Plant & Equipment (PP&E) By Year And By Quarter
Hydrocleanse™ Wound Care – Sonoma Pharmaceuticals
OCLS (NASDAQ) - Oculus Innovative Sciences, Inc. Stock - Fund Sentiment, Institutional Ownership, Shareholders
NASDAQ Oculus Innovative Sciences, Inc. OCLS PriceVolume indicator, Oculus Innovative Sciences, Inc. OCLS indicators PriceVolume technical analysis, Oculus Innovative Sciences, Inc. OCLS indicators PriceVolume free charts, Oculus Innovative Sciences ...
Rx Item-Acuicyn 40 Ml Sol By Oculus Innovative Sciences
Oculus Innovative Sciences Reports Third Quarter Product Revenue Up 19% with a $2.6 Million Reduction in Operating Expenses
Amazon.com: OI847816 - Microcyn Solution with Preservatives 990 mL Bottle : Industrial & Scientific
Oculus Innovative Sciences - Home | Facebook
Oculus Innovative Science Microcyn Wound Care Spray Bottle, 8Oz OI84507
Oculus Innovative Sciences Announces Fiscal Second Quarter 2008 Quarterly Results and Clinical Update
Oculus Innovative Sciences Introduces Microcyn(R) Solution for Use in Post-Surgical Wounds to U.S. Hospitals and Physicians
20041109.Occulus Story.qxp
OCULUS INNOVATIVE SCIENCES INC (SNOA) Property, Plant & Equipment (PP&E) By Year And By Quarter
Oculus Innovative Sciences, Inc. OCLS Support Resistance charts Oculus Innovative Sciences, Inc. OCLS NASDAQ - munafasutra.com
Oculus Innovative Sciences - L-R - Hersteller
Oculus Innovative Sciences - 84781-6
Oculus Innovative Sciences Awarded Damages by Federal Court in Intellectual Property Rights Litigation
Petaluma firm sells part of its Latin American business
